Simpson, Kit; Pei, Pamela; Möller, Jörgen; Baran, Robert - In: PharmacoEconomics 31 (2013) 5, pp. 427-444
A comprehensive simulation of lifetime course of HIV in the USA indicated that using LPV/r as first-line therapy compared with DRV + RTV may result in cost savings, with similar clinical outcomes. </AbstractSection> Copyright Springer International Publishing Switzerland 2013